Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Associate Professor of Medicine and Pediatrics
Dr Fatima Cody Stanford is an obesity medicine physician scientist, educator, and policy maker at Massachusetts General Hospital and Harvard Medical School in Boston, US. She is a national and international sought after expert in obesity medicine who bridges the intersection of medicine, public health, policy, and disparities. View more
Curcumin in Lifestyle Diseases
Author(s): Kana Shimizu , Masafumi Funamoto , Yoichi Sunagawa , et al Added: 3 years ago
Inflammation involves an array of processes in response to tissue damage resulting from oxidative stress or other causes and triggers repair, such as subsequent extracellular matrix remodelling and fibrosis.1–3 Chronic inflammation continues for a prolonged period, lasting from several months to several years, and is characterised by tissue invasion by inflammatory macrophages. This induces the… View more

Prevention & Chronic Conditions
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries, and markets its… View more
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 7 months ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial (NCT04788511). Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese. Patients with… View more

Heart Failure

Prevention & Chronic Conditions
Weight Loss Medications: What You Need to Know in 2024
Author(s): Harold Bays Added: 1 week ago
ACC.24 — Dr Harold E Bays, Science Officer for the Obesity Medicine Association, a member of the Board of Trustees of the Obesity Medicine Association, and a member of the Board of Directors of the American Society of Preventive Cardiology, joins us to highlight key information regarding weight loss medications in 2024.Support: This is an independent interview conducted by Radcliffe Cardiology… View more

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Clinical Research Fellow and Honorary Specialist Registrar in Cardiology